While activating mutations in FLT3 are relatively rare in infants suffering from ALL, the overexpression of wild-type FLT3, causing autoactivation, is a notable characteristic and high-risk factor in KMT2A-r leukemias [68]. This evidence concerns the gene FLT3 and acute lymphoblastic leukemia.